Today’s top gainers include the company Incyte Corporation (NASDAQ:INCY) which is in the industry Biotechnology, gaining 1.61% today. In the last week its performance is 5.57%, and 10.59% for the past quarter. Currently, Incyte Corporation, INCY has a target price of 92, so today’s gain of 1.61% is a significant step towards its target price. The GAP today is therefore -0.46%.
Incyte Corporation (NASDAQ:INCY), has a market cap of 15212.44, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 99.10%.
At the current price of 81.27, it has a dividend yield of *TBA, and its target price is 92. This is with a profit margin of 5.70%, and total debt/equity of 0. Incyte Corporation (NASDAQ:INCY) has a P/E of 385.17, as well as a forward P/E of 62.23.
With a current EPS of 0.21, and a forecasted EPS growth for next year at 3527.78%,Incyte Corporation (NASDAQ:INCY) has had a EPS growth for the past five years at 16.40%. For the next five years EPS growth is projected to be 38.70%.
Performance for the year is -23.03%. Since its IPO date on 11/04/1993, the total performance to date is -25.06%.
Volume today for Incyte Corporation (NASDAQ:INCY), is 786052, while its average volume is 1214.84. Whilst the total gain today was 1.61%, it did have a day high of -7.52%.
Volatility for this week has been at 5.10%, and 4.22% for the month. The 52-week low for Incyte Corporation, INCY has been 47.76%, while the 52-week-high has reached -39.18%.
Looking at its return of investments, which is 6.30%, and its return on assets is 4.90%. Incyte Corporation (NASDAQ:INCY) has an operating margin of 10.90%. With a sales growth of 65.40% quarter over quarter. Bearing in mind that Incyte Corporation, INCY is in the sector Healthcare, its long-term debt/equity is 2.76, and has a current ratio of 4.7 and 4.7 for quick ratio.
So what is the value of Incyte Corporation? Well its PEG is 9.95, and the P/S is 17.73, along with a P/B of 66.61. Meanwhile it has a p/cash of 18.76.